159 related articles for article (PubMed ID: 36088397)
21. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Sankari SL; Mahalakshmi K; Kumar VN
BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
[TBL] [Abstract][Full Text] [Related]
22. Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation.
Ali A; Soares AB; Eymael D; Magalhaes M
J Pathol Clin Res; 2021 Jan; 7(1):61-74. PubMed ID: 33001588
[TBL] [Abstract][Full Text] [Related]
23. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.
Porter S; Gueiros LA; Leão JC; Fedele S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):603-611. PubMed ID: 29891084
[TBL] [Abstract][Full Text] [Related]
25. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
[TBL] [Abstract][Full Text] [Related]
26. Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
Chen X; Hu Q; Wu T; Wang C; Xia J; Yang L; Cheng B; Chen X
Int J Oncol; 2018 Mar; 52(3):733-742. PubMed ID: 29328386
[TBL] [Abstract][Full Text] [Related]
27. Connexin 43, Bcl-2, Bax, Ki67, and E-cadherin patterns in oral squamous cell carcinoma and its relationship with GJA1 rs12197797 C/G.
Segura IG; Secchi DG; Galíndez MF; Carrica A; Bologna-Molina R; Brunotto M; Centeno VA
Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e366-e374. PubMed ID: 35717615
[TBL] [Abstract][Full Text] [Related]
28. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
29. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation?
Shen ZY; Liu W; Feng JQ; Zhou HW; Zhou ZT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Nov; 112(5):592-6. PubMed ID: 21868266
[TBL] [Abstract][Full Text] [Related]
31. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
[No Abstract] [Full Text] [Related]
32. Frequency of cd44 expression in diagnosed cases of oral Epithelial dysplasia and squamous cell carcinoma.
Momin Z; Rahat N; Shahzad H; Umair M; Kaleemi R; Khursheed A
J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S762-S768. PubMed ID: 38406907
[TBL] [Abstract][Full Text] [Related]
33. Wound healing after therapy of oral potentially malignant disorders with a 445-nm semiconductor laser: a randomized clinical trial.
Meisgeier A; Heymann P; Ziebart T; Braun A; Neff A
Clin Oral Investig; 2023 Dec; 28(1):26. PubMed ID: 38147181
[TBL] [Abstract][Full Text] [Related]
34. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.
Agha-Hosseini F; Sheykhbahaei N; SadrZadeh-Afshar MS
J Contemp Dent Pract; 2016 Aug; 17(8):692-701. PubMed ID: 27659090
[TBL] [Abstract][Full Text] [Related]
36. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
Coletta RD; Salo T
Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
[TBL] [Abstract][Full Text] [Related]
37. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
38. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
Juneja S; Chaitanya NB; Agarwal M
Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for oral epithelial dysplasias to become malignant: clinical implications.
Gómez-Armayones S; Chimenos-Küstner E; Arranz C; Tous S; Marquez S; Penín RM; Quirós B; Taberna M; Alemany L; Servitje O; Mena M
Int J Oral Maxillofac Surg; 2022 Apr; 51(4):473-480. PubMed ID: 34503889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
